ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

Contract For NCI CIS Service Center Awarded To Fred Hutchinson

December 11, 2009

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976